At $149, neither EHEL nor any SCAR retention is baked into $AVAV
The SCAR loss sucks, but it’s created massive asymmetry. The market is obsessing over one piece of the BlueHalo acquisition while completely missing how much more relevant Locust, Titan, Halo Shield, and the rest
